Thomas Hoang, MD

University of British Columbia, Canada

Poster(s):

• P0831 - Real-World Outcomes of a Mandatory Adalimumab Non-Medical Biosimilar Switch for Patients With Inflammatory Bowel Disease: A Single Center Retrospective Study
  Sunday, October 27, 2024

  3:30 PM – 7:00 PM ET